home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,364 rows where filing_year = 2022 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • second_quarter 355
  • third_quarter 347
  • first_quarter 332
  • fourth_quarter 330

issue_code 1

  • MED · 1,364 ✖

filing_year 1

  • 2022 · 1,364 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2769087 O'NEILL AND ASSOCIATES 90808ceb-73b6-4ab4-8cc8-bbf5a9805b19 1T O'NEILL AND ASSOCIATES 73134 ANALOGIC 2022 first_quarter MED medical technology HOUSE OF REPRESENTATIVES,SENATE 5500   0 1 2022-02-07T08:52:37.947000-05:00
2769373 FRANCIS EDWARD & CRONIN, INC. 75a5dcf9-bbed-44b6-a6a0-dd4596c8a13a Q1 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2022 first_quarter MED Issues and legislation related to Alzheimer's disease research Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 20000   0 0 2022-04-01T08:52:55-04:00
2769374 FRANCIS EDWARD & CRONIN, INC. d17c312b-bbc8-446d-93b0-80836f2aad90 Q1 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2022 first_quarter MED Issues and legislation related to diabetes treatment and diagnosis HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,Veterans Affairs, Dept of (VA)     0 0 2022-04-01T08:54:58-04:00
2769586 MARSHALL BRACHMAN ad808937-b025-4e19-acb6-3bea610b31ba Q1 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2022 first_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2022-04-03T14:43:25-04:00
2769609 RAY C CULVER III 260cdd44-3582-4946-9382-f2c8321cb11a Q1 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2022 first_quarter MED FY2022 Consolidated Appropriations Act, Division A funding for USDA ARS human nutrition research centers HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2022-04-03T21:03:54-04:00
2769610 RAY C CULVER III 220a0d91-861a-4c0e-a734-404e4662860d 1A RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2022 first_quarter MED FY2022 Consolidated Appropriations Act, Division A funding for USDA ARS human nutrition research centers HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-03T21:12:43-04:00
2769718 MAGILL ASSOCIATES, LLC bbf60b9e-4de3-44a7-81f2-6d24bba19911 Q1 MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2022 first_quarter MED H.R. 2471 - Consolidated Appropriations Act, 2022 FY 2022 appropriations for the development of a synthetic vaccine Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-04T11:30:35-04:00
2769846 AMERICAN COLLEGE OF CLINICAL PHARMACY 7fe58b10-f35c-499a-83fb-6cd4c6644efa Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2022 first_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2022-04-04T17:45:12-04:00
2769936 AUBURN HEALTH STRATEGIES, LLC a11f5afe-a893-4f7b-a196-1783d39fcac7 Q1 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2022 first_quarter MED Proficiency testing for clinical laboratories Health & Human Services, Dept of (HHS)     0 0 2022-04-05T11:23:25-04:00
2769937 AUBURN HEALTH STRATEGIES, LLC f77c3a10-3843-443d-925c-b1f3fcfa9877 Q1 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2022 first_quarter MED Proficiency testing for clinical laboratories Health & Human Services, Dept of (HHS)     0 0 2022-04-05T11:23:36-04:00
2769974 MUSCULAR DYSTROPHY ASSOCIATION, INC. 9b17da81-b39a-4ef7-8ae6-23a961f4245d Q1 MUSCULAR DYSTROPHY ASSOCIATION, INC. 400348610 MUSCULAR DYSTROPHY ASSOCIATION, INC. 2022 first_quarter MED Advocated in favor of robust appropriations funding for the National Institutes of Health, the Food and Drug Administration, the Health Resources and Services Administration, and the Centers for Disease Control and Prevention. Advocated for greater appropriations for the National Center for Advancing Translational Sciences (NCATS) Advocated for greater appropriations for the National Institutes of Health. Advocated for appropriations for HHS, NIH, and FDA to implement the ACT for ALS. Provided feedback and comments to the Senate's PREVENT Act. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   100000 0 0 2022-04-05T14:19:01-04:00
2770152 COVINGTON & BURLING LLP 3fbe6b76-fdd1-412a-8fe7-35eca3640643 Q1 COVINGTON & BURLING LLP 11195 SL 2T, LLC ("SMARTLABS") 2022 first_quarter MED Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments, including relating to the PREVENT Pandemics Act (S. 3799) and the ARPA-H Act (H.R. 5585). HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2022-04-06T13:47:17-04:00
2770204 AMERICAN GASTROENTEROLOGICAL ASSOCIATION ba8c9559-6fcd-45b0-97df-dd8672079173 Q1 AMERICAN GASTROENTEROLOGICAL ASSOCIATION 59650 AMERICAN GASTROENTEROLOGICAL ASSOCIATION 2022 first_quarter MED Lobbied in support of increased federal research funding for the NIH, VA, and DoD's Congressionally Directly Medical Research Program. Lobbied in support of H.R. 289/H.R. 869, the RISE Act, to provide $25 billion in research funding to research facilities whose research was disrupted due to the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2022-04-06T15:57:05-04:00
2770262 THE HARRIS FIRM 78e4f507-001e-4a04-a139-7dbc4899863f Q1 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2022 first_quarter MED Issues pertaining to cannabis CSA scheduling. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-06T19:10:35-04:00
2770477 MARSHFIELD CLINIC HEALTH SYSTEM 66264752-4b68-429b-9cc6-8a3ab9643d6e Q1 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2022 first_quarter MED COVID-19, agricultural occupational health, NIOSH HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2022-04-07T23:30:10-04:00
2770649 PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY c623570e-ef8f-4ef2-9d1e-479d8fc19102 Q1 PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY 401106232 PROTON THERAPY CONSORTIUM FKA NATIONAL ASSOCIATION FOR PROTON THERAPY 2022 first_quarter MED Commercial insurance coverage for radiation oncology; Physician fee schedule; HOPPS 2022; RO APM Model; Medicare & Medicaid coverage for radiation oncology; proton therapy Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-08T11:04:14-04:00
2770710 MCDERMOTT+ LLC 1887485a-ee75-42e8-87c1-2d54252dc26e Q1 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2022 first_quarter MED Issues concerning regulation of laboratory-developed tests. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2022-04-08T12:42:47-04:00
2770980 THE PETRIZZO GROUP, INC. e89c9a1f-94c5-4a70-b6f7-d9fee978efd8 Q1 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2022 first_quarter MED Advancing initiatives to fund research of the immune system in underserved and understudied population communities to detect and prevent a downward spiral of vulnerable patients in this pandemic and future pandemics. Advocating for funding of research to develop a specialized suite of ethnically diverse and tissue-specific cell lines with accessible, stable, and reproducible human cell lines that are representative of our diverse population. HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2022-04-09T16:41:56-04:00
2770984 THE PETRIZZO GROUP, INC. 99a7affa-aa4a-4732-bc5c-9bcd7a8053ea Q1 THE PETRIZZO GROUP, INC. 305932 IBIO, INC. 2022 first_quarter MED Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and development of domestic advanced vaccine manufacturing platforms. COVID-19 pandemic preparedness. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-09T16:47:54-04:00
2770986 THE PETRIZZO GROUP, INC. 648e7da4-f02d-4479-b162-227b22a75f8d Q1 THE PETRIZZO GROUP, INC. 305932 IMMUNITYBIO, INC. 2022 first_quarter MED Federal support for next generation COVID-19 vaccine technology research, development and manufacturing, approval and distribution. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 60000   0 0 2022-04-09T16:52:57-04:00
2771115 THE PETRIZZO GROUP, INC. 5e0b702a-eb36-4afe-9010-01b34ec91193 Q1 THE PETRIZZO GROUP, INC. 305932 ACCESS TO ADVANCED HEALTH INSTITUTE 2022 first_quarter MED Advocating for funding for COVID-19 vaccine and therapy development and manufacturing; funding for flu vaccine, support adjuvant inclusion in COVID-19 countermeasures. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2022-04-10T12:06:10-04:00
2771122 THE PETRIZZO GROUP, INC. c77910c4-9f82-49a8-b1b6-36e46cfa6a60 Q1 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2022 first_quarter MED Pediatricians Accelerate Childhood Therapies Act of 2021 Increased NIH funding for pediatric research HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2022-04-10T12:12:39-04:00
2771130 THE PETRIZZO GROUP, INC. b483e22a-0a69-4784-930a-4284468eb0e1 Q1 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2022 first_quarter MED Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. NO PAIN Act HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-04-10T12:17:48-04:00
2771202 THE CONSILIO GROUP e978ff25-24f9-48fa-a143-ffb4edad5471 Q1 THE CONSILIO GROUP 400374717 DETECTACHEM 2022 first_quarter MED Chemical detection test for COVID-19 Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office 16500   0 0 2022-04-11T09:30:33-04:00
2771403 UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 60725d83-6bfd-4491-91ce-62d423573cba Q1 UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 89235 UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2022 first_quarter MED Issues related to pandemic preparedness. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   35000 0 0 2022-04-11T12:01:56-04:00
2771537 THE PRENDA GROUP LLC aafff3d0-cbb1-43af-a843-cd76d0987f0b Q1 THE PRENDA GROUP LLC 401104543 UV-CONCEPTS 2022 first_quarter MED Emergency response to COVID-19 Pandemic. Assistance to Hospitals / Veterans Administration Facilities / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. Coronavirus Response and Relief HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-11T14:00:43-04:00
2771541 THE PRENDA GROUP LLC b0932b2f-9e3a-4b5a-ae24-f3aa2b8be4fe Q1 THE PRENDA GROUP LLC 401104543 UV-CONCEPTS 2022 first_quarter MED Emergency response to COVID-19 Pandemic. Assistance to Hospitals / Veterans Administration Facilities / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. Coronavirus Response and Relief HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-11T14:01:02-04:00
2771690 THE CJR GROUP, INC. d4bb5597-edcf-4786-8446-60bfe48f8e55 Q1 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2022 first_quarter MED Issues related to COVID-19 and funding for hospitals HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2022-04-11T19:19:52-04:00
2771947 MICHIGAN TECHNOLOGICAL UNIVERSITY 5d537083-8aa4-4434-a4ca-ac63d655de20 Q1 MICHIGAN TECHNOLOGICAL UNIVERSITY 25181 MICHIGAN TECHNOLOGICAL UNIVERSITY 2022 first_quarter MED Discussed issues of interest related to higher education for the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2022-04-12T11:09:04-04:00
2772025 CHAMBER HILL STRATEGIES 48621ffe-5dcb-4a0e-919c-0c27093dd355 Q1 CHAMBER HILL STRATEGIES 400645947 SANFORD HEALTH 2022 first_quarter MED H.R. 6000, Cures 2.0 Act. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-04-12T11:53:05-04:00
2772319 RELX INC. 88f3029e-991b-401b-bf08-5d9766b6a817 Q1 RELX INC. 49511 RELX INC 2022 first_quarter MED Issues related to US-UK Cancer Summit and Cancer Moonshot initiative. Issues related to NIHs diversity, equity, inclusion and accessibility efforts. Health & Human Services, Dept of (HHS)   520000 0 0 2022-04-12T15:51:20-04:00
2772438 BOSE PUBLIC AFFAIRS GROUP 50484d2d-bcab-4921-8930-76ce1e21ba86 Q1 BOSE PUBLIC AFFAIRS GROUP 297294 AMERICAN ACADEMY OF ANESTHESIOLOGIST ASSISTANTS 2022 first_quarter MED issues related to licensure Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2022-04-12T16:57:31-04:00
2772519 FEDERAL SOLUTIONS, LLC 189df676-cbb9-4fd3-9b85-471860d8f9a4 Q1 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2022 first_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-12T18:39:48-04:00
2772621 EFB ADVOCACY, LLC b5eede66-8a3c-4d71-b0a3-ae58fb2a848b Q1 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2022 first_quarter MED Funding Issues Related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-13T09:46:07-04:00
2772752 BEN BARNES GROUP LP 8b9fe306-d1d4-47a1-aba2-72a7d3cb4842 Q1 BEN BARNES GROUP LP 5415 HUNTSMAN CORPORATION 2022 first_quarter MED CMS Medicare HOUSE OF REPRESENTATIVES,SENATE 18750   0 0 2022-04-13T11:07:06-04:00
2772760 BEN BARNES GROUP LP ce469cf3-8885-455c-bef2-5c6416ba23c7 Q1 BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2022 first_quarter MED Medical/Disease Research HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2022-04-13T11:13:11-04:00
2772816 IMPACT MANAGEMENT GROUP a7bf36d3-c158-4a0b-912b-28a6b499549c Q1 IMPACT MANAGEMENT GROUP 401104137 ARKANSAS RESEARCH ALLIANCE 2022 first_quarter MED On behalf of client support continued and future funding for clinical research programs in Arkansas HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-13T11:54:45-04:00
2773008 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 83cc059c-dfb7-4073-83c3-28bdc0038e91 Q1 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2022 first_quarter MED AACC joined with other healthcare groups in writing to the Senate HELP leadership endorsing S.3534, the Tracking Pathogens Act, which would support and enhance existing genomic sequencing and surveillance activities. AACC met with House and Senate staff urging that the Verifying Accurate Leading-edge IVCT Development (VALID) Act not be included in the Medical Device User Fee Amendments V legislative package that will be considered by Congress. AACC provided input to the Senate HELP committee on its draft "Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act," which would rebuild and strengthen our nations public health infrastructure. HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2022-04-13T14:50:02-04:00
2773101 AMERICAN ASSOCIATION FOR CANCER RESEARCH 56e4c60d-4020-49fa-b2b1-3bc3ee9a5ac5 Q1 AMERICAN ASSOCIATION FOR CANCER RESEARCH 400601833 AMERICAN ASSOCIATION FOR CANCER RESEARCH 2022 first_quarter MED Cancer research Oncology product review at the FDA Pediatric research and cancer care Clinical trials Diversity in clinical trials HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2022-04-13T15:57:46-04:00
2773370 MCHUGH LEMAY ASSOC., LLC c50088e4-72bc-4015-b3b2-2f381eff6512 Q1 MCHUGH LEMAY ASSOC., LLC 401105253 CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2022 first_quarter MED Issues related to COVID testing - including the National Defense Authorization Act of 2023 (Not yet introduced). Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2022-04-13T18:34:11-04:00
2773422 NATURAL RESOURCE RESULTS LLC d5e5a30c-ed87-4bdc-9920-f42818a8f2f9 Q1 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2022 first_quarter MED Support funding at DOE for fusion technology development. SENATE 30000   0 0 2022-04-13T20:18:29-04:00
2773444 BRAMER GROUP LLC 42498bda-5e65-4ac4-a665-baa5c85bbd36 Q1 BRAMER GROUP LLC 401103355 TACTICAL MEDICAL SOLUTIONS, LLC 2022 first_quarter MED Medical Training, FY 2022 NDAA Army, Dept of (Other),Defense, Dept of (DOD) 8250   0 0 2022-04-13T20:45:37-04:00
2773507 HELIX, INC. 21a144d7-d22e-4ae9-8419-e0895dcbdc4c Q1 HELIX, INC. 401106164 HELIX, INC. 2022 first_quarter MED genomic research and testing, COVID-19 testing and research Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE,White House Office   36520 0 0 2022-04-14T09:04:20-04:00
2773510 DREXEL UNIVERSITY 6f845dbf-cca2-4e9f-b1d2-f630c04f6272 Q1 DREXEL UNIVERSITY 40032273 DREXEL UNIVERSITY 2022 first_quarter MED Research, education and other matters related to higher ed. HOUSE OF REPRESENTATIVES,SENATE   81000 0 0 2022-04-14T09:04:54-04:00
2773515 DREXEL UNIVERSITY 32cc3bd0-c464-4c51-8a4d-23f490dc7bb6 Q1 DREXEL UNIVERSITY 40032273 ST. CHRISTOPHER'S HOSPITAL FOR CHILDREN 2022 first_quarter MED Children's health and welfare HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-14T09:09:07-04:00
2773821 60 PLUS ASSOCIATION dc8372e7-e8b4-4002-946b-995e968f2dd1 Q1 60 PLUS ASSOCIATION 41988 60 PLUS ASSOCIATION 2022 first_quarter MED Support legislation that would revamp laboratory data reporting requirements under the Protecting Access to Medicare Act (PAMA). HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-14T12:13:30-04:00
2774250 FAMILIES USA FOUNDATION, INC. e3fd2cc6-bb36-42b4-9ed8-a98fceb056cf Q1 FAMILIES USA FOUNDATION, INC. 14108 FAMILIES USA FOUNDATION INC 2022 first_quarter MED S.1644Promising Pathway ActTo amend the Federal Food, Drug, and CosmeticActto establish a time-limited provisional approvalpathway, subject to specific obligations, for certain drugs and biological products, and for other purposes. HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2022-04-14T14:36:36-04:00
2774329 HACKENSACK MERIDIAN HEALTH dcdfdce2-0e2d-4300-a85d-a9ab7c0c11cd Q1 HACKENSACK MERIDIAN HEALTH 401104109 HACKENSACK MERIDIAN HEALTH 2022 first_quarter MED National Institutes of Health funding Biomedical research and the creation of ARPA-H Support for the Center for Discovery and Innovation HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   160000 0 0 2022-04-14T15:25:22-04:00
2774350 DESIMONE CONSULTING, LLC 0842717a-c2e0-4289-8549-5c05d43cb39d Q1 DESIMONE CONSULTING, LLC 400931695 WE WORK FOR HEALTH 2022 first_quarter MED Issues related to access to medicines and other medical therapies, the development of new medical therapies, pharmaceutical supply chain and regulatory matters regarding the biopharmaceutical industry; PDUFA Reauthorization; FY2022 Budget Reconciliation (H.R.5376). HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-14T15:36:00-04:00
2774415 HAWLEY LLC f1d74385-df3a-4c26-837c-e0f8cad5522f Q1 HAWLEY LLC 401105460 MLA ASSOCIATES ON BEHALF OF CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2022 first_quarter MED Issues related to pathogen testing for COVID 19 and other diseases, including the not yet introduced National Defense Authorization Act for FY2023 Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-14T15:54:14-04:00
2774638 GOVERNMENT COUNSEL, LLC 386312be-17a8-4aba-a832-d5e0a2f9d1cd Q1 GOVERNMENT COUNSEL, LLC 401105070 HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) 2022 first_quarter MED S.2209/H.R.4128-Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2022-04-14T18:31:12-04:00
2774781 FAEGRE DRINKER BIDDLE & REATH LLP 4cd47678-deec-4373-8cc1-9c1c9fd25dd5 1T FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2022 first_quarter MED Issues related to neglected diseases research and development, access, and drug pricing; COVID treatments research and development.       0 1 2022-04-15T09:08:06-04:00
2774807 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER fcee4152-0716-4b1a-bb86-796730c86dfd Q1 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2022 first_quarter MED CHGME, NIH, PACT ACT, Genomics, Cures 2.0, ARP Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   34560 0 0 2022-04-15T09:18:52-04:00
2775052 STANFORD UNIVERSITY 31e5dda3-918d-4907-a4e2-1b552d07a9c1 Q1 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2022 first_quarter MED H.R.708; S.168 Temporary Reciprocity to Ensure Access to Treatment Act H.R. 2256, S. 834 Resident Physician Shortage Reduction Act of 2021 Title VII HRSA Health Professions programs HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2022-04-15T11:33:40-04:00
2775501 WASHINGTON UNIVERSITY IN ST. LOUIS b68efb52-5a30-4d38-ad16-f15670459022 Q1 WASHINGTON UNIVERSITY IN ST. LOUIS 40031264 WASHINGTON UNIVERSITY IN ST LOUIS 2022 first_quarter MED General advocacy for NIH and other biomedical research. General advocacy supporting the continued responsible utilization of research animals. General support for the development of fair and effective organ transplant policies. HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2022-04-15T14:05:13-04:00
2775660 CORNERSTONE GOVERNMENT AFFAIRS, INC. 8689d831-c5bc-4eac-be70-b1f365692861 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 2022 first_quarter MED Congressional outreach related to health care issues. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-15T15:18:33-04:00
2775761 THE CORMAC GROUP, LLC 6b5c121f-a4ed-44be-a0c6-9981f9fe472a Q1 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2022 first_quarter MED Appropriations, DOD, TBI Research, Veterans Issues Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-15T16:12:40-04:00
2775784 O'NEILL AND ASSOCIATES 4c87f995-b834-489f-a6be-3054f2010307 Q1 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2022 first_quarter MED healthcare, medical HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2022-04-15T16:19:38-04:00
2776001 FORBES-TATE 45d560d5-0e70-4652-9624-4d6204098667 Q1 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2022 first_quarter MED Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-15T18:04:05-04:00
2776029 FORBES-TATE 28cbeef6-57ba-434a-971a-9a881d6041bb Q1 FORBES-TATE 400976792 AMGEN USA, INC. 2022 first_quarter MED Issues related to Biosimilars. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-15T18:27:50-04:00
2776099 FORBES-TATE aa9540ac-048f-419f-b039-3ab692de7d8f Q1 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2022 first_quarter MED Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-15T20:01:24-04:00
2776129 FORBES-TATE 59b8d1a2-6f93-4f4c-b8f7-e1ea200fcf69 Q1 FORBES-TATE 400976792 COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION 2022 first_quarter MED Issues pertaining to government-wide federal regulation of cannabis. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2022-04-15T20:36:57-04:00
2776135 FORBES-TATE 2768fb45-274e-46c1-9a96-1406b5161e2e Q1 FORBES-TATE 400976792 CSL BEHRING 2022 first_quarter MED Issues related to COVID-19 response efforts. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-15T21:07:18-04:00
2776523 FOLEY & LARDNER LLP 82c7a5ec-3aea-4ba9-926a-13df9491c5d9 Q1 FOLEY & LARDNER LLP 15042 CARDIAC RMS 2022 first_quarter MED Remote Cardiac Monitoring HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-16T14:13:48-04:00
2776538 K&L GATES, LLP 485ba042-543a-4e6a-8d37-8f36c946b029 Q1 K&L GATES, LLP 32098 CHEMBIO DIAGNOSTICS, INC. 2022 first_quarter MED Issues related to disease diagnostics testing and manufacturing - no specific legislation. Health & Human Services, Dept of (HHS) 10000   0 0 2022-04-16T14:22:05-04:00
2776598 CAPITOL COUNSEL LLC e5f4d2b6-40a4-4874-9311-8e9b63462e39 Q1 CAPITOL COUNSEL LLC 313715 BLUE EARTH DIAGNOSTICS, INC. 2022 first_quarter MED To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-16T15:31:30-04:00
2776626 CAPITOL COUNSEL LLC 7a01cb6c-473d-4283-9906-89f4108d14fa Q1 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2022 first_quarter MED Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-16T16:01:12-04:00
2776663 CAPITOL COUNSEL LLC 8dbc3d08-93e6-476f-9df2-462ab90db6dd Q1 CAPITOL COUNSEL LLC 313715 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2022 first_quarter MED Monitor health and tax legislation pertaining to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-16T16:18:47-04:00
2776844 FOLEY & LARDNER LLP e193a3c7-cdf1-42a9-bfda-2cc0f62d9537 Q1 FOLEY & LARDNER LLP 15042 RHYTHM MANAGEMENT GROUP 2022 first_quarter MED Remote Cardiac Monitoring HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-16T22:11:15-04:00
2776861 FOLEY & LARDNER LLP 8a94a480-2a11-432d-93b7-3c44ba68b1f8 Q1 FOLEY & LARDNER LLP 15042 VECTOR REMOTE CARE 2022 first_quarter MED Remote Cardiac Monitoring HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-16T22:37:05-04:00
2776967 AMERICAN SOCIETY OF ADDICTION MEDICINE a538f628-93d4-49e7-9496-79aed89551dc Q1 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2022 first_quarter MED Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This Program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for increased appropriations for HRSAs Integrated Substance Use Disorder Training Program. This program provides grants to expand the number of nurse practitioners, physician assistants, psychologists, and social workers trained to provide addiction and mental health services in underserved community-based settings that integrate primary care, mental health, and addiction services. Advocated for increased appropriations for federal initiatives that lead to a more diverse addiction treatment workforce, such as scholarships and loan repayment targeting underrepresented minority addiction medicine professionals, including SAMHSAs Minority Fellowship Program. Advocated for the alignment of coverage and payment policies in Medicare and Medicaid with evidence-based and nationally recognized addiction treatment and placement criteria and standards (e.g., The ASAM Criteria). This would include permanent modification to the Institutions for Mental Diseases (IMD) exclusion to allow federal Medicaid funds to serve individuals with SUDs in those residential and inpatient settings that are able to demonstrate that patient assessments, clinical services, level-of-care and length-of-stay recommendations are consistent with The ASAM Criteria and that evidence based medication management using Food and Drug Administration (FDA)-approved medications are available to patients in such settings. Advocated for regulatory/sub-regulatory/application guidance th… Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   90000 0 0 2022-04-17T10:29:17-04:00
2777194 CLARK STREET ASSOCIATES 83f2fad4-db8d-4a6c-990b-180b8856e8c7 Q1 CLARK STREET ASSOCIATES 401105692 QORVO 2022 first_quarter MED Issues related to COVID testing including National Defense Authorization Act for FY 2023 (not yet introduced). Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 180000   0 0 2022-04-17T13:16:04-04:00
2777596 CORNERSTONE GOVERNMENT AFFAIRS, INC. 9bd7417b-a541-4c94-a2f1-f905ac53e70c Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CHILDREN'S NATIONAL MEDICAL CENTER 2022 first_quarter MED Representation on health-related issues including reimbursement, research, public-health & clinical care Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2022-04-17T21:49:00-04:00
2777623 CORNERSTONE GOVERNMENT AFFAIRS, INC. b8b62dcc-9035-41c2-9e26-0c1460ff2544 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CITY OF HOPE MEDICAL CENTER 2022 first_quarter MED Medicare/Medicaid reimbursement, clinical research HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-17T22:17:15-04:00
2777676 MICHAEL N. MCCARTY LAW OFFICE PLLC 7f459b1d-24d6-44df-b2cc-f7b7819fbb89 Q1 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2022 first_quarter MED Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-18T01:08:31-04:00
2777691 MARSHALL & POPP, LLC b654b8fe-adde-444d-a230-bb32d6579364 Q1 MARSHALL & POPP, LLC 401105121 BUTTERFLY NETWORK, INC. 2022 first_quarter MED Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T06:45:44-04:00
2777724 IMPACT MANAGEMENT GROUP 6de2b5c2-a5b4-4f09-904a-08d98cc4d0c0 Q1 IMPACT MANAGEMENT GROUP 401104137 CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. 2022 first_quarter MED Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021 HOUSE OF REPRESENTATIVES     0 0 2022-04-18T08:24:33-04:00
2777840 MANATOS & MANATOS d34e649c-cab5-47d3-91ac-20acd2ca437d Q1 MANATOS & MANATOS 23634 BARBARA ANN KARMANOS CANCER INSTITUTE 2022 first_quarter MED PPS-exemption HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-18T09:31:06-04:00
2778059 TIBER CREEK GROUP cdde247e-a5e2-4d1b-ada5-d875a321db65 Q1 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2022 first_quarter MED Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T10:42:43-04:00
2778458 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS bd7fe340-684b-48b2-b28a-6fb519e0fff4 Q1 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 52105 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 2022 first_quarter MED Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries. Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act HOUSE OF REPRESENTATIVES,SENATE   353803 0 0 2022-04-18T11:59:33-04:00
2778510 UNIVERSITY OF IOWA f317819a-7343-4d29-b261-db5cf36abf1f Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2022 first_quarter MED Support for robust funding for federal agencies that fund medical and disease research HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2022-04-18T12:08:43-04:00
2778572 SQUIRE PATTON BOGGS 1abcc167-866e-4a9b-bfed-69435f39765c Q1 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2022 first_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2022-04-18T12:20:11-04:00
2779051 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 5b8ed434-308a-456f-b6ea-8317485e0fba Q1 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2022 first_quarter MED Pharmaceutical Labeling Food & Drug Administration (FDA) 18700   0 0 2022-04-18T13:28:42-04:00
2779456 BLUEBIRD STRATEGIES e8a0feb4-1146-42fc-b677-183629a0637c Q1 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2022 first_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal Year 2023 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-18T14:42:28-04:00
2779469 BLUEBIRD STRATEGIES c9c5a4b1-4356-4b9d-9d97-b0db24c1bce4 Q1 BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2022 first_quarter MED Legislation to regulate clinical labs under CLIA and FDA. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-18T14:45:28-04:00
2779931 POWERS PYLES SUTTER & VERVILLE, P.C. 23c928ff-d008-4f9f-8b6f-ec09e308c9cd Q1 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 GATEWAYS HOSPITAL & MENTAL HEALTH CENTER FOUNDATION 2022 first_quarter MED FY 2022 Consolidated Appropriations Act, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 5376 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills FY 2023 House, Senate Departments of Transportation, Housing and Urban Development, and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills Administration for Children & Families (ACF),Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Bureau of Justice Assistance,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Office of Justice Program,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 15000   0 0 2022-04-18T15:58:31-04:00
2779952 THE CONAFAY GROUP, LLC f0df2f30-12f8-498c-b54b-5e6057b2f874 Q1 THE CONAFAY GROUP, LLC 401004840 ACADIA PHARMACEUTICALS INC. 2022 first_quarter MED Pharmaceutical research/Medicare and Medicaid Reform HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-18T16:01:08-04:00
2779997 THE CONAFAY GROUP, LLC b03b8a11-1496-4fe1-9dbf-888da067dee8 Q1 THE CONAFAY GROUP, LLC 401004840 EMERGEX VACCINES HOLDING LTD. 2022 first_quarter MED Infectious disease, influenza and respiratory disease research       0 0 2022-04-18T16:11:02-04:00
2780117 POWERS PYLES SUTTER & VERVILLE, P.C. e3b2f6a3-7e73-4dd4-a1ad-33f0d7e8d3e5 Q1 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 CORNERSTONE CARE, INC. 2022 first_quarter MED FY 2022 Consolidated Appropriations Act, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 537 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Comprehensive Addiction and Recovery Legislation House, Senate Legislation to Reform Behavioral Health and Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals and Health Centers House, Senate Infrastructure Bills Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of     0 0 2022-04-18T16:28:48-04:00
2780128 BRACEWELL LLP 47e2d871-7845-43da-b7c0-a08d3b4571f4 Q1 BRACEWELL LLP 6837 AIR LIQUIDE USA LLC 2022 first_quarter MED work related to medical gases HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2022-04-18T16:30:45-04:00
2780159 THE CONAFAY GROUP, LLC bd38f645-202a-4cf8-bf8f-006da81cea3e Q1 THE CONAFAY GROUP, LLC 401004840 SECURING AMERICAS MEDICINES AND SUPPLY SAMS 2022 first_quarter MED Strengthening the medical supply chain Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-18T16:34:44-04:00
2780162 IMPACT HEALTH POLICY PARTNERS b4bc9956-50a8-457e-b4f4-cb96882f09e1 Q1 IMPACT HEALTH POLICY PARTNERS 401104696 ABBOTT LABORATORIES 2022 first_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-18T16:34:51-04:00
2780176 IMPACT HEALTH POLICY PARTNERS 26f8da0c-b018-422c-9246-77c243ab2924 Q1 IMPACT HEALTH POLICY PARTNERS 401104696 CHILDREN'S HOSPITAL COLORADO 2022 first_quarter MED Issues related to pediatric research and children's hospital graduate medical education. H.R.6000, Cures 2.0 Act. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-18T16:36:14-04:00
2780254 IMPACT HEALTH POLICY PARTNERS 4a9c1e29-72c6-48d6-9ae0-f89ff5c54cc3 Q1 IMPACT HEALTH POLICY PARTNERS 401104696 HACKENSACK MERIDIAN HEALTH 2022 first_quarter MED Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. H.R.6000, Cures 2.0 Act. HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2022-04-18T16:40:48-04:00
2780274 THE CONAFAY GROUP, LLC 0f8a70e6-1748-4516-b956-312746d47efd Q1 THE CONAFAY GROUP, LLC 401004840 THE COALITION FOR THE ADVANCEMENT OF RESEARCH AND INNOVATION IN TRAUMA (CARIT) 2022 first_quarter MED Support for trauma research Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-18T16:43:49-04:00
2780364 THE CONAFAY GROUP, LLC 307c0566-055b-4768-888a-3b44c94a4bf5 Q1 THE CONAFAY GROUP, LLC 401004840 ANI PHARMACEUTICALS 2022 first_quarter MED Support for medical research HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-18T16:55:17-04:00
2780481 THE CONAFAY GROUP, LLC 053405a2-0ece-40ce-bb93-668d3486caaa Q1 THE CONAFAY GROUP, LLC 401004840 CURIA GLOBAL, INC. (FORMERLY KNOWN AS ALBANY MOLECULAR RESEARCH, INC.) 2022 first_quarter MED Federal support to advance medical research Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-18T17:18:35-04:00
2780627 POWERS PYLES SUTTER & VERVILLE, P.C. 84cb4a1f-57e7-4ca3-84b1-94d60cb644d8 Q1 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 PIH HEALTH FOUNDATION 2022 first_quarter MED FY 2022 Consolidated Appropriations Act, H.R. 2471, now P.L. 117-103 American Rescue Plan Act of 2021, H.R. 1319, now P.L. 117-2 Infrastructure Investment and Jobs Act, H.R. 3684, now P.L. 117-58 Build Back Better Act, H.R. 5376 CONNECT for Health Act, S. 1512, H.R. 2903 FY 2023 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2023 House, Senate Department of Agriculture Appropriations Bills FY 2023 House, Senate Departments of Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2023 House, Senate Financial Services and General Government Appropriations Bills FY 2023 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Train More Primary Care and Other Providers House Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 30000   0 0 2022-04-18T18:02:04-04:00
2780907 THE RABEN GROUP 57b372bb-4c91-41ac-8b37-6823956f7c7d Q1 THE RABEN GROUP 61458 EXAGEN INC 2022 first_quarter MED Educate House and Senate members on the uses of a Lupus early diagnosis test HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-18T20:26:00-04:00
2780997 BLUESTONE STRATEGIES, LLC e2fd2423-ab42-40d5-bdc6-9078e20244d9 Q1 BLUESTONE STRATEGIES, LLC 400658980 VALYRIAN SMOKE LLC 2022 first_quarter MED Medical Research and Funding for Traumatic Brain Injury and Post-Traumatic Stress Disorder HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-18T21:14:10-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1664.31ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API